Dan Devine, chief business officer and general counsel of Vaxxas. Courtesy photo Former Pfizer Exec Takes Legal Reins at Needle-Free Vaccine Company
"The company's technology platform and the vaccine products that it enables offer a rare opportunity to fundamentally change the way vaccines are developed and distributed worldwide," said Dan Devine, chief business officer and general counsel of Vaxxas.
April 13, 2022 at 09:21 PM
1 minute read
News
Australia- and U.S.-based biotechnology company Vaxxas, which is seeking to commercialize a needle-free vaccination technology, has added Dan Devine as chief business officer and general counsel.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View All
Google Fails to Secure Long-Term Stay of Order Requiring It to Open App Store to Rivals
Rates Will Go Up (Again), But Here's Why Profitability Might Not Be Maximized
4 minute read
Trending Stories
- 1The Law Firm Disrupted: Playing the Talent Game to Win
- 2A&O Shearman Adopts 3-Level Lockstep Pay Model Amid Shift to All-Equity Partnership
- 3Preparing Your Law Firm for 2025: Smart Ways to Embrace AI & Other Technologies
- 4BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 5A RICO Surge Is Underway: Here's How the Allstate Push Might Play Out
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
